Thanks. It's just where PMCB is right now. Getting an IND meeting with the FDA is not a simple thing to get. I have invested in companies that had to apply 2 & 3 times. With Dr. Von Hoff's help, scheduled the first time we applied.
This is my 3rd investment in bio and the 3rd time I have been at this stage of the companies attempt at clinical trials. The other two paid off quite well and those companies are off and running. And I made a lot of money on those other two. I used the same formula here and not only are we going to make a lot of money, with the pending buyouts, we are going to make a shitload of money.
Just stay in through the Diabetes buyout and you will be incredibly proud of yourself.
Again, if you confused as to whether or not this is leading to a buyout just check the finances. It would take billions to get CiaB to market for PC and Diabetes. That's not exactly in the budget right now. Therefore....buyout pending.
News 
Market Data 
Discover 
AI
